Inventor · disambiguated record
Michael R. Schrimpf
Also filed as: SCHRIMPF MICHAEL · SCHRIMPF MICHAEL R
37 granted patents·22 pending applications·254 citations·filing 2000–2023
97Inventor score
Top patents by PatentIndex Score
59 records- 0193US8314119B2Azaadamantane derivatives and methods of useSCHRIMPF MICHAEL R·Filed 2007·Granted Nov 20, 2012·22 cites·20 claims
- 0293US6809105B2Diazabicyclic central nervous system active agentsABBOTT LAB·Filed 2001·Granted Oct 26, 2004·53 cites·20 claims
- 0391US6833370B1Heterocycle substituted aminoazacycles useful as central nervous system agentsABBOTT LAB·Filed 2000·Granted Dec 21, 2004·40 cites·7 claims
- 0490US8846661B2Diazahomoadamantane derivatives and methods of use thereofSCHRIMPF MICHAEL R·Filed 2010·Granted Sep 30, 2014·17 cites·20 claims
- 0590US7399765B2Substituted diazabicycloalkane derivativesABBOTT LAB·Filed 2004·Granted Jul 15, 2008·33 cites·16 claims
- 0685US8987453B2Azaadamantane derivatives and methods of useABBVIE INC·Filed 2012·Granted Mar 24, 2015·6 cites·6 claims
- 0784US8536221B2Amide derivatives as positive allosteric modulators and methods of use thereofMORTELL KATHLEEN H·Filed 2009·Granted Sep 17, 2013·14 cites·5 claims
- 0883US10508113B2Inhibitors of tyrosine kinase 2 mediated signalingABBVIE INC·Filed 2019·Granted Dec 17, 2019·3 cites·30 claims
- 0983US8163916B2Azaadamantane ester and carbamate derivatives and methods of use thereofSCHRIMPF MICHAEL R·Filed 2008·Granted Apr 24, 2012·5 cites·12 claims
- 1083US7365193B2Amino-substituted tricyclic derivatives and methods of useABBOTT LAB·Filed 2005·Granted Apr 29, 2008·3 cites·7 claims
- 1183US2024360124A1Bromodomain InhibitorsABBVIE INC·Filed 2023·Application pending·0 cites
- 1281US8648074B2Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockersABBVIE INC·Filed 2012·Granted Feb 11, 2014·6 cites·25 claims
- 1380US8940762B2Methods for treating painLEE CHIH-HUNG·Filed 2010·Granted Jan 27, 2015·11 cites·4 claims
- 1480US7897766B2Amino-aza-adamantane derivatives and methods of useABBOTT LAB·Filed 2006·Granted Mar 1, 2011·3 cites·4 claims
- 1579US8119635B2Diazabicyclic central nervous system active agentsSCHRIMPF MICHAEL R·Filed 2009·Granted Feb 21, 2012·2 cites·9 claims
- 1679US8076350B2Spirocyclic azaadamantane derivatives and methods of useJI JIANGUO·Filed 2007·Granted Dec 13, 2011·3 cites·6 claims
- 1778US7786171B2Amide derivatives as positive allosteric modulators and methods of use thereofABBOTT LAB·Filed 2009·Granted Aug 31, 2010·3 cites·6 claims
- 1877US8586746B2Amino-aza-adamantane derivatives and methods of useSCHRIMPF MICHAEL R·Filed 2011·Granted Nov 19, 2013·3 cites·7 claims
- 1976US9063126B2Indole and indoline derivatives and methods of use thereofSCHRIMPF MICHAEL R·Filed 2009·Granted Jun 23, 2015·2 cites·9 claims
- 2076US8524703B2Bridgehead amine ring-fused indoles and indolinesSHI LEI·Filed 2010·Granted Sep 3, 2013·3 cites·30 claims
- 2176US7994223B2Amide derivatives as positive allosteric modulators and methods of use thereofABBOTT LAB·Filed 2010·Granted Aug 9, 2011·3 cites·5 claims
- 2274US8163914B2Acetamide and carboxamide derivatives of azaadamantane and methods of use thereofSCANIO MARC J C·Filed 2008·Granted Apr 24, 2012·3 cites·9 claims
- 2374US7319106B2Diazabicyclic central nervous system active agentsABBOTT LAB·Filed 2004·Granted Jan 15, 2008·5 cites·20 claims
- 2473US8691865B2Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockersSEARLE XENIA B·Filed 2011·Granted Apr 8, 2014·4 cites·23 claims
- 2570US2022017511A1Bromodomain InhibitorsABBVIE INC·Filed 2021·Application pending·0 cites
- 2668US9625475B2Indole and indoline derivatives and methods of use thereofSCHRIMPF MICHAEL R·Filed 2010·Granted Apr 18, 2017·1 cites·8 claims
- 2768US7598236B2Diazabicyclic central nervous system active agentsABBOTT LAB·Filed 2007·Granted Oct 6, 2009·0 cites·19 claims
- 2867US7750022B2Quinuclidine derivatives and their pharmaceutical useNEUROSEARCH AS·Filed 2004·Granted Jul 6, 2010·3 cites·7 claims
- 2967US7332504B2Heterocyclic substituted aminoazacycles useful as central nervous system agentsABBOTT LAB·Filed 2004·Granted Feb 19, 2008·2 cites·6 claims
- 3067US2020255426A1Bromodomain InhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 3165US7951791B2Amino-substituted tricyclic derivatives and methods of useABBOTT LAB·Filed 2008·Granted May 31, 2011·0 cites·4 claims
- 3260US2008090798A1Heterocyclic Substituted Aminoazacycles Useful as Central Nervous System AgentsABBOTT LAB·Filed 2007·Application pending·0 cites
- 3359US2024043386A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE GLOBAL ENTPR LTD·Filed 2023·Application pending·0 cites
- 3459US2008167286A1Pharmaceutical compositions and their methods of useABBOTT LAB·Filed 2007·Application pending·0 cites
- 3559US2024158368A1Pyrrolidine Main Protease Inhibitors as Antiviral AgentsABBVIE INC·Filed 2023·Application pending·0 cites
- 3658US2012208820A1Diazabicyclic central nervous system active agentsSCHRIMPF MICHAEL R·Filed 2012·Application pending·0 cites
- 3757US2020255423A1Inhibitors of tyrosine kinase 2 mediated signalingABBVIE INC·Filed 2019·Application pending·0 cites
- 3856US7265115B2Diazabicyclic CNS active agentsABBOTT LAB·Filed 2003·Granted Sep 4, 2007·1 cites·14 claims
- 3952US9983218B2Indole and indoline derivatives and methods of use thereofABBVIE INC·Filed 2017·Granted May 29, 2018·0 cites·2 claims
- 4052US9029361B2Agents for treating pain and uses thereofABBVIE INC·Filed 2013·Granted May 12, 2015·0 cites·22 claims
- 4152US2022213041A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE GLOBAL ENTPR LTD·Filed 2021·Application pending·0 cites
- 4249US9186407B2Pharmaceutical compositions and their methods of useGOPALAKRISHNAN MURALI·Filed 2011·Granted Nov 17, 2015·0 cites·5 claims
- 4348US9382258B2Agents for treating pain and uses thereofABBVIE INC·Filed 2015·Granted Jul 5, 2016·0 cites·3 claims
- 4448US2008255203A1Heterocyclic compounds and their methods of useABBOTT LAB·Filed 2007·Application pending·0 cites
- 4548US2016022658A1Pharmaceutical compositions and their methods of useABBVIE INC·Filed 2015·Application pending·0 cites
- 4648US2012190704A1Azaadamantane ester and carbamate derivatives and methods of use thereofSCHRIMPF MICHAEL R·Filed 2012·Application pending·0 cites
- 4747US8268853B23,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereofSCHRIMPF MICHAEL R·Filed 2010·Granted Sep 18, 2012·0 cites·12 claims
- 4847US2015158867A1Azaadamantane derivatives and methods of useABBVIE INC·Filed 2015·Application pending·0 cites
- 4946US2012065219A1Spirocyclic azaadamantane derivatives and methods of useJI JIANGUO·Filed 2011·Application pending·0 cites
- 5045US2022211692A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE GLOBAL ENTPR LTD·Filed 2021·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael R. Schrimpf files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →